Kidney Cancer

>

Latest News

A prospective trial established that 97% of patients were successfully discharged on the same day as receiving robotic partial nephrectomy.
Outpatient Robotic Partial Nephrectomy Is Safe/Feasible for Renal Tumors

April 29th 2025

A prospective trial established that 97% of patients were successfully discharged on the same day as receiving robotic partial nephrectomy.

Time to deterioration in physical functioning and role functioning was similar among those receiving belzutifan vs everolimus for renal cell carcinoma.
Belzutifan Improves Disease-Specific Symptoms/QOL vs Everolimus in RCC

April 6th 2025

Fruquintinib/Sintilimab Meets PFS End Point in Advanced or Metastatic RCC
Fruquintinib/Sintilimab Meets PFS End Point in Advanced or Metastatic RCC

March 19th 2025

Data from the phase 3 ZIRCON study support the biologics license application for TLX250-CDx in clear cell renal cell carcinoma imaging.
FDA Grants Priority Review to TLX250-CDx in Clear Cell RCC Imaging

February 26th 2025

Longer progression-free survival and more enduring responses occurred with avelumab/axitinib vs sunitinib in the phase 3 JAVELIN Renal 101 trial.
Avelumab Combo Improves Long-Term Efficacy Vs Sunitinib in Advanced RCC

February 26th 2025

More News